- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/115 - Paramyxoviridae, p. ex. virus para-influenza
Détention brevets de la classe C07K 14/115
Brevets de cette classe: 151
Historique des publications depuis 10 ans
|
8
|
8
|
9
|
3
|
10
|
7
|
6
|
16
|
12
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 365 |
6 |
| University of Georgia Research Foundation, Inc. | 1019 |
6 |
| Boehringer Ingelheim Vetmedica GmbH | 1267 |
5 |
| Centre National de La Recherche Scientifique | 10350 |
5 |
| Institute for Research in Biomedicine | 98 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
5 |
| Board of Regents, The University of Texas System | 5754 |
4 |
| Janssen Vaccines & Prevention B.V. | 295 |
4 |
| Zoetis Services LLC | 1538 |
4 |
| Les Hospices Civils de Lyon | 3 |
3 |
| Universite Claude Bernard Lyon 1 | 1013 |
3 |
| Icosavax, Inc. | 37 |
3 |
| Glaxosmithkline Biologicals S.A. | 1635 |
2 |
| Biocomo Inc. | 9 |
2 |
| Crucell Holland B.V. | 92 |
2 |
| Dynavax Technologies Corporation | 116 |
2 |
| Icahn School of Medicine at Mount Sinai | 936 |
2 |
| ID Biomedical Corporation of Quebec | 19 |
2 |
| ID Pharma Co., Ltd. | 43 |
2 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2774 |
2 |
| Autres propriétaires | 82 |